|
| 1 |
miR-4487 Enhances Gefitinib-Mediated Ubiquitination and Autophagic Degradation of EGFR in Non–Small Cell Lung Cancer Cells by Targeting USP37
Mi Seong Kim, So Hui Kim, Sei Hoon Yang, Min Seuk Kim
Cancer Res Treat.2022;54(2):445-457. Published online 2021 August 3
DOI: http://dx.doi.org/10.4143/crt.2021.622
|
|
| 2 |
The Risk of Herpes Zoster in Patients with Non-small Cell Lung Cancer according to Chemotherapy Regimens: Tyrosine Kinase Inhibitors versus Cytotoxic Chemotherapy
Ji Young Choi, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Seong Jin Jo
Cancer Res Treat.2019;51(1):169-177. Published online 2018 April 5
DOI: http://dx.doi.org/10.4143/crt.2017.491
|
|
| 3 |
Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial
Jin Hyoung Kang, Myung-Ju Ahn, Dong-Wan Kim, Eun Kyung Cho, Joo-Hang Kim, Sang Won Shin, Xin Wang, Jong Seok Kim, Mauro Orlando, Keunchil Park
Cancer Res Treat.2016;48(2):458-464. Published online 2015 October 14
DOI: http://dx.doi.org/10.4143/crt.2015.135
|
|
| 4 |
The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib
Dong Il Park, Sun Young Kim, Ju Ock Kim, Sung Soo Jung, Hee Sun Park, Jae Young Moon, Chae Uk Chung, Song Soo Kim, Jae Hee Seo, Jeong Eun Lee
|
|
| 5 |
Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients
Seung-Hoon Beom, Dong-Wan Kim, Sung Hoon Sim, Bhumsuk Keam, Jin Hyun Park, Jeong-Ok Lee, Tae Min Kim, Se-Hoon Lee, Dae Seog Heo
|
|
| 6 |
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
Young Saing Kim, Eun Kyung Cho, Hyun Sun Woo, Junshik Hong, Hee Kyung Ahn, Inkeun Park, Sun Jin Sym, Sun Young Kyung, Shin Myung Kang, Jeong-Woong Park, Sung Hwan Jeong, Jinny Park, Jae Hoon Lee, Dong Bok Shin
|
|
| 7 |
Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
Yon Ju Ryu, Eun Mi Chun, Soon Nam Lee, Sung Shin Shim
|
|
| 8 |
Radiation Recall Dermatitis Induced by Gefitinib
Beodeul Kang, Ah Young Leem, Young Jae Kim, Eudong Hwang, Yujung Yun, Sun Wook Kim, Hyo Song Kim
Ewha Med J.2013;36(Suppl):S17-S21. Published online 2013 December 23
DOI: http://dx.doi.org/10.12771/emj.2013.36.S.S17
|
|
| 9 |
Post-Progression Survival in Patients with Non-Small Cell Lung Cancer with Clinically Acquired Resistance to Gefitinib
Hyojeong Kim, Tak Yun, Young Joo Lee, Ji-Youn Han, Heung Tae Kim, Geon Kook Lee
|
|
| 10 |
How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, Jeong-Ok Lee, Tae Min Kim, Se-Hoon Lee, Doo Hyun Chung, Dae Seog Heo
Cancer Res Treat.2013;45(3):178-185. Published online 2013 September 30
DOI: http://dx.doi.org/10.4143/crt.2013.45.3.178
|
|
| 11 |
Repeated Favorable Responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in a Case of Advanced Lung Adenocarcinoma
Eun-Young Kim, Yoon-Hee Kim, Hee-Jung Ban, In-Jae Oh, Yong-Soo Kwon, Kyu-Sik Kim, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim
|
|
| 12 |
Gefitinib in Selected Patients with Pre-Treated Non-Small-Cell Lung Cancer: Results from a Phase IV, Multicenter, Non-Randomized Study (SELINE)
Kwan-Ho Lee, Kye-Young Lee, Young-June Jeon, Maan-Hong Jung, Choonhee Son, Min-Ki Lee, Jeong-Seon Ryu, Sei-Hoon Yang, Jae-Cheol Lee, Young-Chul Kim, Sun-Young Kim
|
|
| 13 |
A Case of Miliary Brain Metastasis of Lung Cancer Mimicking Neurocysticercosis
Ho-Jun Lee, In-Jae Oh, Sang-Woo Park, Hee-Jung Ban, Young-Chul Kim, Soo-Ok Kim
|
|
| 14 |
Enhanced Sensitivity to Gefitinib after Radiation in Non-Small Cell Lung Cancer Cells
Yun Jung Choi, Jin Kyung Rho, Dae Hyun Back, Hye-Ryoun Kim, Jae Cheol Lee, Cheol Hyeon Kim
|
|
| 15 |
Successful Rechallenge with Gefitinib for an Initial Erlotinib-Responder with Advanced Lung Adenocarcinoma
Sung Chul Hong, Yun Su Sim, Jin Hwa Lee, Yon Ju Ryu, Jung Hyun Chang
|
|
| 16 |
Comparison of Therapeutic Efficacy of Gefitinib and Erlotinib in Patients with Squamous Cell Lung Cancer
Hong-Joon Shin, Tae-Ok Kim, Hyun-Wook Kang, Su-Young Chi, Hee-Jung Ban, Soo-Ok Kim, Yong-Soo Kwon, In-Jae Oh, Kyu-Sik Kim, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim
|
|
| 17 |
Could HBx Protein Expression Affect Signal Pathway Inhibition by Gefitinib or Selumetinib, a MEK Inhibitor, in Hepatocellular Carcinoma Cell Lines?
Yoon Kyung Park, Kang Mo Kim, Young-Joo Lee, Ki-Hun Kim, Sung-Gyu Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh
|
|
| 18 |
The Effect of Gefitinib on Immune Response of Human Peripheral Blood Monocyte-Derived Dendritic Cells
Jin Hoon Cho, Mi Hyun Kim, Kwang Ha Lee, Ki Uk Kim, Doo Soo Jeon, Hye Kyung Park, Yun Seong Kim, Min Ki Lee, Soon Kew Park
|
|
| 19 |
Serum Carcinoembryonic Antigen as an Index of the Therapeutic Effect of EGFR-TKIs in Patients with Advanced Non-Small Cell Lung Cancer
Jin Hee Park, Sung Bin Kim, Sung Jin Nam, Su Hyeon Jeong, Chul Ho Oak, Tae Won Jang, Maan Hong Jung
J Lung Cancer.2010;9(2):97-102. Published online 2010 January 10
DOI: http://dx.doi.org/10.6058/jlc.2010.9.2.97
|
|
| 20 |
Comparison of Gefitinib versus Docetaxel in Patients with Pre-Treated Non-Small Cell Lung Cancer (NSCLC)
Vera Hirsh
J Lung Cancer.2009;8(2):61-66. Published online 2009 January 10
DOI: http://dx.doi.org/10.6058/jlc.2009.8.2.61
|
|
